Israel Englander Hookipa Pharma Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.59 - $1.04 $611 - $1,077	-1,036 Reduced 2.52%	40,137 $23,000
Q1 2024 May 15, 2024	SELL	$0.61 - $0.83 $10,041 - $13,663	-16,462 Reduced 28.56%	41,173 $29,000
Q4 2023 Feb 14, 2024	SELL	$0.42 - $0.86 $24,688 - $50,551	-58,781 Reduced 50.49%	57,635 $46,000
Q2 2023 Aug 14, 2023	SELL	$0.71 - $1.97 $202,612 - $562,178	-285,370 Reduced 71.03%	116,416 $102,000
Q1 2023 May 15, 2023	SELL	$0.72 - $1.03 $52,745 - $75,455	-73,258 Reduced 15.42%	401,786 $296,000
Q4 2022 Feb 14, 2023	BUY	$0.73 - $14.6 $67,852 - $1.36 Million	92,949 Added 24.33%	475,044 $385,000
Q3 2022 Nov 14, 2022	SELL	$1.27 - $15.0 $407,216 - $4.81 Million	-320,643 Reduced 45.63%	382,095 $512,000
Q2 2022 Aug 15, 2022	BUY	$1.33 - $2.31 $934,641 - $1.62 Million	702,738 New	702,738 $1.15 Million
Q1 2022 May 16, 2022	SELL	$1.26 - $2.52 $355,057 - $710,115	-281,792 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.33 - $5.94 $477 - $1,217	-205 Reduced 0.07%	281,792 $657,000
Q3 2021 Nov 15, 2021	SELL	$5.89 - $9.35 $623,868 - $990,352	-105,920 Reduced 27.3%	281,997 $1.66 Million
Q2 2021 Aug 16, 2021	BUY	$9.16 - $19.51 $3.55 Million - $7.57 Million	387,917 New	387,917 $3.55 Million
Q1 2021 May 17, 2021	SELL	$10.64 - $14.7 $274,139 - $378,745	-25,765 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$9.32 - $13.63 $145,615 - $212,955	15,624 Added 154.07%	25,765 $286,000
Q3 2020 Nov 16, 2020	SELL	$8.59 - $11.89 $197,398 - $273,232	-22,980 Reduced 69.38%	10,141 $96,000
Q2 2020 Aug 14, 2020	BUY	$7.23 - $12.1 $239,464 - $400,764	33,121 New	33,121 $385,000
Q3 2019 Nov 14, 2019	SELL	$6.45 - $8.44 $314,418 - $411,424	-48,747 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$6.16 - $14.15 $300,281 - $689,770	48,747 New	48,747 $328,000

Others Institutions Holding HOOK

# of Institutions

Shares Held

713K

Call Options Held

Put Options Held

View Full List

About HOOKIPA Pharma Inc.

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $173M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

More about HOOK

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account